Clinical Trial Update: Oxaliplatin, Irinotecan, and Capecitabine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Cannot Be Removed By Surgery [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating a three-drug combination of oxaliplatin, irinotecan, and capecitabine for advanced or metastatic colorectal cancer that cann…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Camptosar (irinotecan)
• Eloxatin (oxaliplatin)
• Xeloda (capecitabine)

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED